Skip to main content

Medicines safety

General information about the safety of medicines and how it is monitored. This includes various kinds of reviews of specific medicines guidelines and monitoring by the TGA.

Latest alerts

  • Sitagliptin

    Safety advisory - low levels of contamination with a nitrosamine impurity
  • Shortage of tenecteplase (Metalyse)

    Boehringer Ingelheim (BI) has advised the Therapeutic Goods Administration (TGA) of a shortage of tenecteplase (Metalyse) injection that is predicted to extend over the next 18 months.

Latest articles

Latest publications

Help us improve the Therapeutic Goods Administration site